GlassScriptPhysician profile
Mohamed S Jasser
NPI 1154392330
$5,352.02
in general payments reported to CMS, 2019-2025
42 companies · $43.34 in 2025
The $43.34 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,214 · 2020: $447 · 2021: $764 · 2022: $348 · 2023: $724 · 2024: $811 · 2025: $43.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,559 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,559.02 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $814.52 | 2019 | |
| Janssen Pharmaceuticals, INC | $642.48 | 2019-2022 | |
| Medtronic Vascular, INC. | $622.38 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $385.70 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $345.02 | 2021-2024 | Verquvo, Dificid, Zerbaxa |
| Irhythm Technologies, INC. | $323.45 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals LP | $198.65 | 2019-2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $182.64 | 2019-2024 | Lifevest |
| Novo Nordisk INC | $135.83 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| Philips North America LLC | $128.87 | 2020-2024 | (Cm9) Amb Mon & Diag Und |
| E.R. Squibb & Sons, L.L.C. | $119.83 | 2019-2023 | Camzyos |
| Abbott Laboratories | $110.94 | 2019-2024 | Jot Dx, Assurity |
| Biotronik INC. | $110.28 | 2019-2025 | Orsiro Mission, Nhancer Rx |
| Cook Medical LLC | $101.38 | 2024 | Cook Celect |
| Pfizer INC. | $86.16 | 2019-2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $81.44 | 2023-2024 | |
| Boston Scientific Corporation | $77.03 | 2020-2023 | Ekosonic |
| Cvrx, INC. | $74.76 | 2021-2023 | Barostim Neo System |
| Portola Pharmaceuticals, LLC | $70.32 | 2019-2020 | |
| Medtronic, INC. | $68.59 | 2023-2024 | Ffrangio, Onyx Frontier |
| Impulse Dynamics (USA) INC. | $62.99 | 2023 | Optimizer |
| Amgen INC. | $50.34 | 2019-2020 | |
| Surmodics, INC. | $46.99 | 2023 | Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Cardiovascular Systems INC. | $46.51 | 2019 | |
| Cardiva Medical, INC. | $43.53 | 2023-2024 | Optowire, Cardiva Vascade 6/7f Vcs |
| Esperion Therapeutics, INC. | $41.56 | 2021-2022 | |
| Ethicon US, LLC | $34.23 | 2021 | |
| Paratek Pharmaceuticals, INC. | $34.13 | 2022-2023 | Nuzyra |
| Silk Road Medical, INC. | $33.63 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Amarin Pharma, INC. | $31.79 | 2019 | |
| Bard Peripheral Vascular, INC. | $31.28 | 2022-2024 | Rotarexs 6 F X 135 Cm |
| Vifor Pharma, INC. | $31.09 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $30.22 | 2023 | Exparel |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.34 | 2023-2024 | Jardiance |
| Strongbridge US INC. | $26.88 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $17.93 | 2023 | Arcalyst |
| Emd Serono, INC. | $16.86 | 2020 | |
| Angiodynamics, INC. | $15.85 | 2021 | |
| Braemar Manufacturing, LLC | $12.47 | 2019 | |
| Medicomp INC | $11.97 | 2021 | |
| Chiesi USA, INC. | $11.59 | 2020 | |
| Celonova Biosciences, INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Jasser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.